Location History:
- Kikuchi, JP (2020)
- Kikuyo-machi, JP (2022)
Company Filing History:
Years Active: 2020-2025
Title: Innovations of Miyuki Matsumoto in Vaccine Development
Introduction
Miyuki Matsumoto is a prominent inventor based in Kikuchi, Japan, known for her significant contributions to the field of vaccine development. With a total of four patents to her name, she has focused her research on preventing and treating congenital infections, particularly those caused by cytomegalovirus (CMV). Her work is vital in advancing medical science and improving public health.
Latest Patents
Matsumoto's latest patents include a vaccine designed to prevent or treat congenital infection with cytomegalovirus. This innovative vaccine comprises a CMV envelope glycoprotein B (gB protein) antigen and a pentamer antigen. The objective of this invention is to provide an effective vaccine capable of preventing and treating congenital infections caused by CMV. Another notable patent involves a modified CMV gB protein that can induce a group of antibodies, including a high ratio of neutralizing antibodies. This modified protein exhibits enhanced neutralizing activity against CMV gB compared to the wild type, making it a promising candidate for the prevention and treatment of CMV infections.
Career Highlights
Miyuki Matsumoto has made remarkable strides in her career, particularly in the field of biotechnology. Her work at Km Biologics Co., Ltd. has positioned her as a leader in vaccine research and development. Her innovative approaches and dedication to her field have garnered attention and respect from her peers.
Collaborations
Matsumoto collaborates with esteemed colleagues such as Hiroyuki Shimizu and Masaharu Torikai. These partnerships enhance her research efforts and contribute to the advancement of vaccine technology.
Conclusion
Miyuki Matsumoto's contributions to vaccine development, particularly in combating congenital infections caused by cytomegalovirus, highlight her innovative spirit and dedication to improving health outcomes. Her work continues to inspire future advancements in the field of biotechnology.